about the author

Josh Sullivan

josh@endpointsnews.com

author articles

On a jour­ney to dras­ti­cal­ly speed up cell ther­a­py man­u­fac­tur­ing, Ky­topen lands $30M Se­ries A

4 years ago
Financing
Startups

Covid-19 roundup: Nor­mal life is in sight, but not with­out fur­ther vac­ci­na­tions — Bourla; For the 3rd time, EU ...

4 years ago
Coronavirus

Covid-19 roundup: SAB's an­ti­body treat­ments move to PhI­II; Af­ter long jour­ney, No­vavax sub­mits vac­cine to WHO for ...

4 years ago
Coronavirus

Till­man Gern­gross project out of Dart­mouth Col­lege ac­quired by Repli­gen

4 years ago
Deals
Manufacturing

Lon­za un­veils new ex­pan­sion plans at Swiss man­u­fac­tur­ing sites, cap­ping off a very busy pan­dem­ic

4 years ago
Manufacturing

Take­da breaks ground on ze­ro-emis­sion site in Asia; Boston Labs emerges from stealth with mo­bile cell, gene ther­a­py ...

4 years ago
Manufacturing

Catal­ent inks deal with Phath­om to make GI drug at re­cent­ly-ren­o­vat­ed Ken­tucky site

4 years ago
Outsourcing
Manufacturing

Re­call re­port: Pfiz­er pulls even more Chan­tix lots as ni­trosamine con­t­a­m­i­na­tion wor­ries grow

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Bharat Biotech turns to oth­er pro­duc­ers to up sup­ply; Brazil, Ar­genti­na land mR­NA ...

4 years ago
Coronavirus
Manufacturing

With world still in sore need of dos­es, Clover says its Covid-19 vac­cine is 67% ef­fec­tive in Phase III

4 years ago
R&D
Coronavirus

Ver­ri­ca hits an­oth­er bump in the road with CMO re­lat­ed let­ter from FDA

4 years ago
FDA+
Manufacturing

Covid-19 roundup: In­dia to re­sume vac­cine ex­ports as its own cam­paign is un­der con­trol; Pfiz­er to file for vac­cine OK ...

4 years ago
R&D

Chi­nese biotech Ever­est signs $550M+ li­cens­ing deal for BTK in­hibitors on heels of Covid-19 pact

4 years ago
Deals
China

Gri­fols drops $1B on Ger­man hold­ing com­pa­ny in con­tin­ued plas­ma push

4 years ago
Deals

AGC un­veils Ger­man ex­pan­sion plans as gene and cell ther­a­py man­u­fac­tur­ing com­pe­ti­tion heats up

4 years ago
Manufacturing

DNA play­er Touch­light dou­bles fundrais­ing this year with lat­est round of pri­vate back­ers on board

4 years ago
Manufacturing

Emer­gent gets a chance to re­deem it­self in mR­NA vac­cine deal with Prov­i­dence Ther­a­peu­tics

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Kenya will add man­u­fac­tur­ing plant, up vac­ci­na­tion sites; South Ko­rea left wait­ing on ...

4 years ago
Coronavirus
Manufacturing

NeuEx­cell strikes deal with Fu­ji­film for stroke gene ther­a­py; J&J ex­pands in Ire­land

4 years ago
Manufacturing

Re­call re­port: Chil­dren's au­to-im­mune dis­ease drug con­t­a­m­i­nat­ed with mold and yeast

4 years ago
Manufacturing

Ser­vices firm Mesa buys out mol­e­c­u­lar di­ag­nos­tics play­er for a cool $300M as ge­net­ics test­ing gains steam

4 years ago
Deals

Covid-19 roundup: Cure­Vac backs out of man­u­fac­tur­ing con­tracts as de­mand dwin­dles; De­spite PhII/III flop, biotech ...

4 years ago
Coronavirus

Ebo­la vac­cine built on same tech­nol­o­gy as Covid-19 jab from J&J shows long-last­ing suc­cess

4 years ago
R&D

French biotech rais­es $75M for new cell ther­a­py man­u­fac­tur­ing tech, Parkin­son's treat­ment

4 years ago
Financing
Cell/Gene Tx
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times